WuXi AppTec opens second NJ-based site following ongoing expansion efforts

By Melissa Fassbender contact

- Last updated on GMT

New Jersey State Senator Linda Greenstein attended the grand opening. (Image: WuXi AppTec)
New Jersey State Senator Linda Greenstein attended the grand opening. (Image: WuXi AppTec)
WuXi AppTec is converting its Plainsboro, NJ lab into a fully GLP-regulated bioanalytics facility after opening a new site in Cranbury which doubles the company’s total operation space to more than 115,000 square feet.

“The company’s strength in bioanalytical and DMPK services has been heavily driven by increasing customer demand for regulatory-compliant solutions over the past two to three years,” ​said Dr. Jason Liu, SVP of WuXi AppTec, COO of the Laboratory Testing Division.

“The site expansion bolsters WuXi’s Laboratory Testing Division in these services and establishes New Jersey site as a center of excellence in providing IND and NDA enabling services,​” he told us.

When fully configured, Liu said the new facility add 55,000 square feet of laboratory space to WuXi AppTec’s Laboratory Testing Division (LTD) as well as more than 200 new jobs.

“This addition expands upon our established Plainsboro facility, offering testing services to pharmaceutical and biotech companies,”​ he explained.

Additionally, “through the expansion efforts,”​ Liu said the company will be converting its current Plainsboro laboratory into a fully good laboratory practice (GLP) regulated bioanalytics facility with double the space.

WuXi’s Laboratory Testing Division provides in vivo​ and in vitro​ assays from early screening to clinical sample analysis, as well as medical device testing from development to product lifecycle management.

Related news

Show more

Related products

show more

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Related suppliers

Follow us

Products

View more

Webinars